Literature DB >> 18419855

Multiclonal outbreak of methicillin-resistant Staphylococcus aureus infections on a collegiate football team.

A J Hall1, D Bixler, L E Haddy.   

Abstract

An outbreak of methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections (SSTIs) occurred in a college football team in August 2006. Of 109 players on the team roster, 88 (81%) were interviewed during a cohort investigation. Twenty-five cases were identified, six of which were culture-confirmed. Available culture isolates were typed by pulsed-field gel electrophoresis (PFGE), which identified two different MRSA strains associated with the outbreak. Playing positions with the most physical contact (offensive linemen, defensive linemen, and tight ends) had the greatest risk of infection [risk ratio (RR) 5.1, 95% confidence interval (CI) 2.3-11.5. Other risk factors included recent skin trauma (RR 1.9, 95% CI 0.95-3.7), use of therapeutic hydrocollator packs (RR 2.5, 95% CI 1.1-5.7), and miscellaneous training equipment use (RR 2.1, 95% CI 1.1-4.1). The outbreak was successfully controlled through team education and implementation of improved infection-control practices and hygiene policies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18419855     DOI: 10.1017/S095026880800068X

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  10 in total

1.  Survey of high school athletic programs in Iowa regarding infections and infection prevention policies and practices.

Authors:  Mark Pedersen; Matthew R Doyle; Alan Beste; Daniel J Diekema; M Bridget Zimmerman; Loreen A Herwaldt
Journal:  Iowa Orthop J       Date:  2013

2.  Infectious disease outbreaks in competitive sports, 2005-2010.

Authors:  Cathal James Collins; Brian O'Connell
Journal:  J Athl Train       Date:  2012 Sep-Oct       Impact factor: 2.860

3.  Practices and procedures to prevent the transmission of skin and soft tissue infections in high school athletes.

Authors:  Stephanie A Fritz; Marcus Long; Claude J Gaebelein; Madeline S Martin; Patrick G Hogan; John Yetter
Journal:  J Sch Nurs       Date:  2012-04-03       Impact factor: 2.835

Review 4.  Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic.

Authors:  Michael Z David; Robert S Daum
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

5.  Community-based intervention to manage an outbreak of MRSA skin infections in a county jail.

Authors:  Abdallah F Elias; Michael S Chaussee; Emily J McDowell; Mark K Huntington
Journal:  J Correct Health Care       Date:  2010-05-12

6.  Evaluation of persistent antimicrobial effects of an antimicrobial formulation.

Authors:  Michael S Ferrara; Ron Courson; Daryl S Paulson
Journal:  J Athl Train       Date:  2011 Nov-Dec       Impact factor: 2.860

7.  Longitudinal Assessment of Colonization With Staphylococcus aureus in Healthy Collegiate Athletes.

Authors:  Natalia Jiménez-Truque; Elizabeth J Saye; Nicole Soper; Benjamin R Saville; Isaac Thomsen; Kathryn M Edwards; C Buddy Creech
Journal:  J Pediatric Infect Dis Soc       Date:  2014-11-05       Impact factor: 3.164

8.  Transmission of methicillin-resistant Staphylococcus aureus to household contacts.

Authors:  F P N Mollema; J H Richardus; M Behrendt; N Vaessen; W Lodder; W Hendriks; H A Verbrugh; M C Vos
Journal:  J Clin Microbiol       Date:  2009-11-18       Impact factor: 5.948

9.  Infection Control Practices and Methicillin-Resistant Staphylococcus aureus Skin Infections: A Survey of Students in US Chiropractic Programs.

Authors:  Jonathon T Egan
Journal:  J Chiropr Med       Date:  2018-06-14

10.  The use of the temporal scan statistic to detect methicillin-resistant Staphylococcus aureus clusters in a community hospital.

Authors:  Meredith C Faires; David L Pearl; William A Ciccotelli; Olaf Berke; Richard J Reid-Smith; J Scott Weese
Journal:  BMC Infect Dis       Date:  2014-07-08       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.